Moin Andrew

Moin Andrew is listed in filings as Director at SAB Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Oct 1, 2025, including 5 public disclosures. Recent filings connect the profile to SAB Biotherapeutics, Inc. (SABS). The current snapshot covers public activity from Jul 24, 2025 to Oct 1, 2025. Reported amounts are shown as $25.0M to $40.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.